XML 132 R114.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation - Summary of Share Based Compensation Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Granted, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 79.96 $ 54.52 $ 96.52
SARs and Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding at Beginning, Number (in shares) 1,124    
Granted, Number (in shares) 254    
Exercised or converted, Number (in shares) (210)    
Forfeited or expired, Number (in shares) (36)    
Outstanding at Ending, Number (in shares) 1,132 1,124  
Vested or expected to vest at End, Number (in shares) 1,118    
Exercisable or convertible at End, Number (in shares) 623    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]      
Outstanding at Beginning, Weighted-Average Exercise Price (in dollars per share) $ 56.79    
Granted, Weighted-Average Exercise Price (in dollars per share) 74.91    
Exercised or converted, Weighted-Average Exercise Price (in dollars per share) 44.08    
Forfeited or expired, Weighted-Average Exercise Price (in dollars per share) 71.02    
Outstanding at End, Weighted-Average Exercise Price (in dollars per share) 62.75 $ 56.79  
Vested or expected to vest at End, Weighted-Average Exercise Price 62.65    
Exercisable or convertible at End, Weighted-Average Exercise Price $ 58.57    
Outstanding at End, Weighted-Average Remaining Contractual Term 6 years 10 months 18 days    
Vested or expected to vest at End, Weighted-Average Remaining Contractual Term 6 years 9 months 18 days    
Exercisable or convertible at End, Weighted-Average Remaining Contractual Term 5 years 7 months 2 days    
Outstanding at End, Aggregate Intrinsic Value $ 16,327    
Vested or expected to vest at End, Aggregate Intrinsic Value 16,234    
Exercisable or convertible at End, Aggregate Intrinsic Value $ 11,585    
Restricted Shares and Units [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Outstanding at Beginning, Number (in shares) 454    
Granted, Number (in shares) 222    
Exercised or converted, Number (in shares) (145)    
Forfeited or expired, Number (in shares) (35)    
Outstanding at End, Number (in shares) 496 454  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Outstanding at Beginning, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 69.55    
Granted, Weighted-Average Grant-Date Fair Value (in dollars per share) 79.96    
Exercised or converted, Weighted-Average Grant-Date Fair Value (in dollars per share) 71.27    
Forfeited or expired, Weighted-Average Grant-Date Fair Value (in dollars per share) 75.56    
Outstanding at End, Weighted-Average Grant-Date Fair Value (in dollars per share) $ 78.03 $ 69.55